top of page

Latest News

Advocacy

La Presse

Sep 28, 2023

Inquiétudes pour l’accès aux médicaments non approuvés (Concerns about access to unapproved drugs)

Read more
Inquiétudes pour l’accès aux médicaments non approuvés (Concerns about access to unapproved drugs)
Featuring:

Julie Carignan

Advocacy

Macleans Canada

Aug 3, 2023

Stories from the frontlines of the fight for access to innovative therapies

Read more
Stories from the frontlines of the fight for access to innovative therapies
Featuring:

Julie Carignan

Press Release

The Ottawa Hospital Research Institute

Apr 13, 2023

Bringing cellular immunotherapy to solid tumours: made-in-Canada approach

Read more
Bringing cellular immunotherapy to solid tumours: made-in-Canada approach
Featuring:

The C3

Press Release

CHUM Press Release

Apr 12, 2023

Personalized Cellular Immunotherapy

Read more
Personalized Cellular Immunotherapy
Featuring:

Dr. Simon Turcotte

Press Release

Canadian Cancer Society

Apr 1, 2023

Building a National Network for People with Biliary Tract Cancers

Read more
Building a National Network for People with Biliary Tract Cancers
Featuring:

The C3

  • Facebook
  • Instagram
  • LinkedIn
  • Youtube
  • Twitter
logoImage.png
leaf-cihr-colour-en_edited.png

The Canadian Cholangiocarcinoma Collaborative (C3) is supported by a Canadian Cancer Society Breakthrough Team Grant in partnership with the Canadian Institutes of Health Research. The granting funds for C3 are managed by The Ottawa Hospital Research Institute, which serves as the lead institute for all collaborative operations.

© 2025 www.cholangio.ca. All rights reserved.

bottom of page